ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
-2.45%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$364M
AUM Growth
+$364M
(-1.2%)
Cap. Flow
+$5.68M
Cap. Flow
% of AUM
1.56%
Top 10 Holdings %
Top 10 Hldgs %
44.42%
Holding
83
New
22
Increased
23
Reduced
12
Closed
25
Top Buys
| 1 |
Cigna
CI
|
$17M |
| 2 |
Icon
ICLR
|
$16.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
$15M |
| 4 |
Tenet Healthcare
THC
|
$14.6M |
| 5 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$9.8M |
Top Sells
| 1 |
OrthoPediatrics
KIDS
|
$19.3M |
| 2 |
AdaptHealth
AHCO
|
$14.7M |
| 3 |
Sanofi
SNY
|
$13.5M |
| 4 |
Becton Dickinson
BDX
|
$13.2M |
| 5 |
CVS Health
CVS
|
$12.6M |
Sector Composition
| 1 | Healthcare | 80.17% |
| 2 | Industrials | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Labcorp
LH
$23.1B
| $17.4M | 4.77% | 62,919 +17,695 | +39% | +$4.88M |
|
|
2
Cigna
CI
$80.3B
| $17M | 4.68% | +71,856 | New | +$17M |
|
|
3
Icon
ICLR
$13.8B
| $16.4M | 4.51% | +79,415 | New | +$16.4M |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $15M | 4.12% | +29,679 | New | +$15M |
|
|
5
Tenet Healthcare
THC
$16.3B
| $14.6M | 4.01% | +217,891 | New | +$14.6M |
|
|
RCM
6
DELISTED
R1 RCM Inc. Common Stock
RCM
| $12.2M | 3.36% | 548,876 +440,630 | +407% | +$9.8M |
|
|
SYNH
7
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $11.7M | 3.2% | 130,238 +24,717 | +23% | +$2.21M |
|
|
IVC
8
DELISTED
Invacare Corporation
IVC
| $11.1M | 3.05% | 1,374,840 +267,728 | +24% | +$2.16M |
|
9
AbbVie
ABBV
$372B
| $9.63M | 2.65% | 85,514 -2,468 | -3% | -$278K |
|
10
Elutia
ELUT
$96.7M
| $8.39M | 2.31% | 873,159 +289,559 | +50% | +$2.78M |
|
11
Ocular Therapeutix
OCUL
$2.12B
| $8.1M | 2.23% | 570,970 +132,037 | +30% | +$1.87M |
|
|
PHAS
12
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $7.92M | 2.18% | 2,129,709 -33,809 | -2% | -$126K |
|
13
Haemonetics
HAE
$2.63B
| $7.86M | 2.16% | 117,904 +102,765 | +679% | +$6.85M |
|
|
EAR
14
DELISTED
Eargo, Inc. Common Stock
EAR
| $7.72M | 2.12% | +193,471 | New | +$7.72M |
|
15
Bio-Rad Laboratories Class A
BIO
$8.06B
| $7.62M | 2.09% | 11,820 -2,964 | -20% | -$1.91M |
|
16
Insmed
INSM
$28.8B
| $7.41M | 2.04% | 260,314 +127,892 | +97% | +$3.64M |
|
17
Hologic
HOLX
$14.9B
| $7.4M | 2.03% | +110,840 | New | +$7.4M |
|
18
Humana
HUM
$36.5B
| $6.99M | 1.92% | +15,791 | New | +$6.99M |
|
19
Bristol-Myers Squibb
BMY
$96B
| $6.75M | 1.86% | 101,081 -132,817 | -57% | -$8.87M |
|
20
Dentsply Sirona
XRAY
$2.85B
| $6.57M | 1.81% | +103,860 | New | +$6.57M |
|
|
ADAP
21
Adaptimmune Therapeutics
ADAP
$15.6M
| $6.56M | 1.8% | 1,539,435 +623,724 | +68% | +$2.66M |
|
|
MTEM
22
DELISTED
Molecular Templates, Inc.
MTEM
| $5.85M | 1.61% | 748,013 +38,653 | +5% | +$302K |
|
|
TRIL
23
DELISTED
Trillium Therapeutics Inc.
TRIL
| $5.83M | 1.6% | 600,788 +122,414 | +26% | +$1.19M |
|
24
Veracyte
VCYT
$2.39B
| $5.61M | 1.54% | +140,211 | New | +$5.61M |
|
25
DarioHealth
DRIO
$22.8M
| $5.53M | 1.52% | 258,774 -59,102 | -19% | -$1.26M |
|